These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1823943)

  • 1. Structure and functional properties of apolipoprotein C-II.
    Wang CS
    Prog Lipid Res; 1991; 30(2-3):253-8. PubMed ID: 1823943
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apolipoprotein C gene and molecular biology].
    Ohni M; Hata Y
    Nihon Rinsho; 1994 Dec; 52(12):3119-23. PubMed ID: 7853699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apolipoprotein C-I].
    Iwamoto N; Yamamoto K
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():114-9. PubMed ID: 11351557
    [No Abstract]   [Full Text] [Related]  

  • 4. [Apolipoprotein C-II].
    Yamamoto K
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():120-4. PubMed ID: 11351558
    [No Abstract]   [Full Text] [Related]  

  • 5. Global structure and dynamics of human apolipoprotein CII in complex with micelles: evidence for increased mobility of the helix involved in the activation of lipoprotein lipase.
    Zdunek J; Martinez GV; Schleucher J; Lycksell PO; Yin Y; Nilsson S; Shen Y; Olivecrona G; Wijmenga S
    Biochemistry; 2003 Feb; 42(7):1872-89. PubMed ID: 12590574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding.
    MacPhee CE; Hatters DM; Sawyer WH; Howlett GJ
    Biochemistry; 2000 Mar; 39(12):3433-40. PubMed ID: 10727238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase.
    Liu H; Talmud PJ; Lins L; Brasseur R; Olivecrona G; Peelman F; Vandekerckhove J; Rosseneu M; Labeur C
    Biochemistry; 2000 Aug; 39(31):9201-12. PubMed ID: 10924113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of apoC-II and lipoprotein lipase deficiency.
    Fojo SS; de Gennes JL; Beisiegel U; Baggio G; Stalenhoef AF; Brunzell JD; Brewer HB
    Adv Exp Med Biol; 1991; 285():329-33. PubMed ID: 1858563
    [No Abstract]   [Full Text] [Related]  

  • 9. [Apolipoprotein C-II deficiency].
    Inadera H
    Nihon Rinsho; 1994 Dec; 52(12):3241-5. PubMed ID: 7853717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II.
    Smith LC; Voyta JC; Catapano AL; Kinnunen PK; Gotto AM; Sparrow JT
    Ann N Y Acad Sci; 1980; 348():213-23. PubMed ID: 6930927
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular cloning and characteristics of a new apolipoprotein C-II mutant identified in three unrelated individuals with hypercholesterolemia and hypertriglyceridemia.
    Pullinger CR; Zysow BR; Hennessy LK; Frost PH; Malloy MJ; Kane JP
    Hum Mol Genet; 1993 Jan; 2(1):69-74. PubMed ID: 8490626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization, structure and reaction mechanism of enzymes involved in plasma lipoprotein metabolism].
    Ikeda Y; Takagi A
    Tanpakushitsu Kakusan Koso; 1987 Dec; 32(13):1529-45. PubMed ID: 3444891
    [No Abstract]   [Full Text] [Related]  

  • 13. Dioxin alters the human low-density and very low-density lipoprotein structure with evidence for specific quenching of Trp-48 in apolipoprotein C-II.
    Arehart E; Giasson G; Walsh MT; Patterson H
    Biochemistry; 2004 Jul; 43(26):8503-9. PubMed ID: 15222761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of apolipoprotein C-II with 1,2-cyclohexanedione and 2,3-butanedione. Role of arginine in the activation of lipoprotein lipase.
    Holdsworth G; Noel JG; Stedje K; Shinomiya M; Jackson RL
    Biochim Biophys Acta; 1984 Jul; 794(3):472-8. PubMed ID: 6743677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence specific 1H-NMR assignments and secondary structure of a carboxy-terminal functional fragment of apolipoprotein CII.
    Lycksell PO; Ohman A; Bengtsson-Olivecrona G; Johansson LB; Wijmenga SS; Wernic D; Gräslund A
    Eur J Biochem; 1992 Apr; 205(1):223-31. PubMed ID: 1555583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of recombinant human apolipoprotein C-II expressed in Escherichia coli.
    Wang CS; Downs D; Dashti A; Jackson KW
    Biochim Biophys Acta; 1996 Aug; 1302(3):224-30. PubMed ID: 8765143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of lipoprotein lipase and hepatic triglyceride lipase.
    Jackson RL; McLean LR; Ponce E; Rechtin A; Demel RA
    Adv Exp Med Biol; 1987; 210():73-7. PubMed ID: 3591558
    [No Abstract]   [Full Text] [Related]  

  • 18. Esterase-type of activity possessed by human plasma apolipoprotein C-II and its synthetic fragments.
    Vainio P; Virtanen JA; Sparrow JT; Gotto AM; Kinnunen PK
    Chem Phys Lipids; 1983 Jul; 33(1):21-32. PubMed ID: 6627523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of apolipoproteins B-100, AI and C from plasma lipoprotein in the goose, Anser anser. Evidence for a genetic polymorphism in ApoC-like apolipoproteins.
    Hermier D; Sellier N; Rousselot-Pailley D; Forgez P
    Eur J Biochem; 1995 Dec; 234(2):586-91. PubMed ID: 8536707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus.
    Allan CM; Walker D; Segrest JP; Taylor JM
    Genomics; 1995 Jul; 28(2):291-300. PubMed ID: 8530039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.